Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options, Issue of Equity & Rule 2.9

21 Dec 2020 15:59

RNS Number : 4225J
Horizon Discovery Group plc
21 December 2020
 

Horizon Discovery Group plc

("Horizon" or the "Company")

 

Exercise of Options, Issue of Equity and Rule 2.9 announcement

 

Cambridge, UK - 21 December 2020: Horizon Discovery Group plc (LSE: HZD), a cell engineering company focused on commercialising the application of gene editing and gene modulation, announces that, following the Court sanctioning the Scheme in relation with the recommended cash offer by PerkinElmer UK earlier today, the Company has today allotted and issued a total of 5,850,657 new ordinary shares of £0.01 each in the Company ("Ordinary Shares") pursuant to the exercise of options. This comprises 4,000,443 options exercised today, 21 December 2020, by certain employees and former employees and 1,850,214 options exercised today by the following PDMRs:

 

Name

Number of options exercised

Respective option plan

Exercise Price per share

Ian Gilham

57,300

EMI Scheme

£0.6774

Ian Gilham

85,950

EMI Scheme

£0.8726

Jayesh Pankhania

17,167

LTIP

£1.7475

Jayesh Pankhania

111,588

LTIP

£1.7475

Jayesh Pankhania

45,064

LTIP

£0.01

Jayesh Pankhania

419,817

LTIP

£1.64

Jayesh Pankhania

57,712

LTIP

£0.01

Siddhartha Kadia

150,000

LTIP

£1.03

Terry Pizzie

60,185

LTIP

£1.62

Terry Pizzie

7,812

LTIP

£0.01

Terry Pizzie

15,031

LTIP

£1.57

Terry Pizzie

41,401

LTIP

£0.01

Terry Pizzie

70,730

LTIP

£0.01

Terry Pizzie

624,594

LTIP

£1.64

Terry Pizzie

85,863

LTIP

£0.01

 

As a result of the option exercises, the PDMRs have increased their shareholdings as detailed below:

 

 

Options exercised in aggregate

No. of ordinary shares in which the Directors (or their close relatives) had an interest before the option exercise

No. of ordinary shares held in the Company following the option exercises

Ian Gilham

143,250

145,592

288,842

Terry Pizzie

905,616

42,285

947,901

Jayesh Pankhania

651,348

90,768

742,116

Siddhartha Kadia

150,000

0

150,000

 

As a result of the exercise of options, application has been made for the 5,850,657 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 22 December 2020. The new Ordinary Shares will rank pari passu with the existing shares of the Company.

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, Horizon confirms that, on 21 December 2020 (the date of this announcement), it has 164,214,591 ordinary shares of £0.01 each in issue. The International Securities Identification Number ("ISIN") for the Company's ordinary shares is GB00BK8FL363.

The above figure (164,214,591) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Capitalised terms used in this announcement (the "Announcement"), unless otherwise defined, have the same meanings as set out in the Scheme Document.

 

Enquiries:

Horizon

Terry Pizzie, Chief Executive Officer Tel: +44 (0) 122365 5580 

Jayesh Pankhania, Chief Financial Officer

Jon Davies, Head of Investor Relations

Evercore (Lead Financial Adviser to Horizon)

Simon Elliott Tel: +44 (0) 20 7653 6000

Edward Banks

Numis (Joint Financial Adviser, Broker and NOMAD to Horizon)

Freddie Barnfield Tel: +44 (0) 20 7260 1000

Stuart Ord

Duncan Monteith

Consilium Strategic Communications (Financial Media and UK Investor Relations Adviser to Horizon)

Mary-Jane Elliott Tel: +44 (0) 7720 088 468

Matthew Neal

Melissa Gardiner

 

1.

Details of Persons Discharging Managerial Responsibilities ('PDMR') / person closely associated with them ('PCA')

a)

Name

Ian Gilham

2.

Reason for notification

a)

Position / status

Non-executive Chairman

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Horizon Discovery Group plc

b)

LEI

213800L812B9NI5M3G89

4.

Details of the transaction(s):

a)

Description of the financial instrument

Identification code

Options over ordinary shares of £0.01 each

ISIN: GB00BK8FL363

b)

Nature of the transaction

Exercise of options

 

c)

Price(s) and volume(s)

 

Number of options

Exercise Price per share

57,300

£0.6774

85,950

£0.8726

 

 

d)

Aggregated information

Aggregated volume

Price

 

143,250

£113,814.99

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

 

1.

Details of Persons Discharging Managerial Responsibilities ('PDMR') / person closely associated with them ('PCA')

a)

Name

Terry Pizzie

2.

Reason for notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Horizon Discovery Group plc

b)

LEI

213800L812B9NI5M3G89

4.

Details of the transaction(s):

a)

Description of the financial instrument

Identification code

Options over ordinary shares of £0.01 each

ISIN: GB00BK8FL363

b)

Nature of the transaction

Exercise of options

 

c)

Price(s) and volume(s)

 

Number of options

Exercise Price per share

60,185

£1.62

7,812

£0.01

15,031

£1.57

41,401

£0.01

70,730

£0.01

624,594

£1.64

85,863

£0.01

d)

Aggregated information

Aggregated volume

Price

 

905,616

£1,147,490.59

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

 

1.

Details of Persons Discharging Managerial Responsibilities ('PDMR') / person closely associated with them ('PCA')

a)

Name

Jayesh Pankhania

2.

Reason for notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Horizon Discovery Group plc

b)

LEI

213800L812B9NI5M3G89

4.

Details of the transaction(s):

a)

Description of the financial instrument

Identification code

Options over ordinary shares of £0.01 each

ISIN: GB00BK8FL363

b)

Nature of the transaction

Exercise of options

 

c)

Price(s) and volume(s)

 

Number of options

Exercise Price per share

17,167

£1.7475

111,588

£1.7475

45,064

£0.01

419,817

£1.64

57,712

£0.01

d)

Aggregated information

Aggregated volume

Price

 

651,348

£914,527.00

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

1.

Details of Persons Discharging Managerial Responsibilities ('PDMR') / person closely associated with them ('PCA')

a)

Name

Siddhartha Kadia

2.

Reason for notification

a)

Position / status

Non-executive Director

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Horizon Discovery Group plc

b)

LEI

213800L812B9NI5M3G89

4.

Details of the transaction(s):

a)

Description of the financial instrument

Identification code

Options over ordinary shares of £0.01 each

ISIN: GB00BK8FL363

b)

Nature of the transaction

Exercise of options

 

c)

Price(s) and volume(s)

 

Number of options

Exercise Price per share

150,000

£1.03

d)

Aggregated information

Aggregated volume

Price

 

150,000

£154,500.00

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMZZKMNGGZM
Date   Source Headline
26th Jan 20187:00 amRNSBlock Listing Six Monthly Return
18th Dec 20177:00 amRNSAgreement with Roche Diagnostics
5th Dec 20177:00 amRNSHZD expand CRISPR license rights with ERS Genomics
24th Nov 20172:54 pmRNSTotal Voting Rights
3rd Oct 20172:10 pmRNSTotal Voting Rights
26th Sep 20177:00 amRNSInterim Results
25th Sep 20173:35 pmRNSHoldings in Company
8th Sep 20177:00 amRNSTrading Update
4th Sep 20173:42 pmRNSHolding(s) in Company
4th Sep 20172:37 pmRNSHolding(s) in Company
31st Aug 20173:30 pmRNSCompletion of Acquisition
24th Aug 20173:56 pmRNSHolding(s) in Company
24th Aug 20173:29 pmRNSHolding(s) in Company
23rd Aug 20178:18 amRNSCompletion of Placing
22nd Aug 20172:12 pmRNSUpdate on Acquisition of GE Healthcare Dharmacon
7th Aug 201710:19 amRNSResult of General Meeting
7th Aug 20177:00 amRNSDirector/PDMR Shareholding
24th Jul 20177:00 amRNSBlock Listing Application
19th Jul 20177:00 amRNSAcquisition and Proposed Placing to Raise £80m
7th Jul 20177:00 amRNSAdditional Listing
4th Jul 20171:55 pmRNSHoldings in Company
3rd Jul 20177:00 amRNSReference Standards support successful FDA filing
28th Jun 201710:57 amRNSResult of AGM
26th Jun 20171:54 pmRNSHolding(s) in Company
16th Jun 20177:00 amRNSAdditional Listing
6th Jun 20177:00 amRNSAdditional Listing
2nd Jun 20177:00 amRNSAnnual Report and Notice of Annual General Meeting
31st May 20177:00 amRNSAdditional Listing
30th May 20177:00 amRNSPreliminary Results Year Ended 31 December 2016
22nd May 20177:00 amRNSHZD Licenses New Gene Editing Technology Platform
9th May 20177:00 amRNSPerformance update in Immuno-Oncology
21st Apr 20177:00 amRNSAdditional Listing
19th Apr 20177:00 amRNSNotice of Results
11th Apr 20172:57 pmRNSHoldings in Company
7th Apr 20175:01 pmRNSGrant of Options
6th Apr 20177:00 amRNSAdditional Listing
30th Mar 20179:08 amRNSHoldings in Company
24th Mar 20177:00 amRNSAdditional Listing
23rd Mar 201711:24 amRNSHoldings in Company
20th Mar 201710:42 amRNSHoldings in Company
14th Mar 20177:00 amRNSAgreement for NIPT Reference Standards
23rd Feb 20177:00 amRNSSite Visit
20th Feb 20171:21 pmRNSHolding(s) in Company
15th Feb 20177:00 amRNSAdditional Listing
14th Feb 20177:00 amRNSMaster Service Agreement with Top 3 Pharma Company
10th Feb 20177:00 amRNSAdditional Listing
31st Jan 20173:06 pmRNSHolding(s) in Company
31st Jan 20177:00 amRNSIssue of Equity
26th Jan 20171:50 pmRNSHolding(s) in Company
24th Jan 20177:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.